NCT06351852View on ClinicalTrials.gov

Transdermal Administration by a Novel Wireless Iontophoresis Device

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

March 22, 2022

Primary Completion Date

September 24, 2024

Study Completion Date

September 24, 2024

Conditions
Spinal Cord InjuriesConstipationFecal IncontinenceNeurogenic Bowel
Interventions
DRUG

Combination of Neostigmine and Glycopyrrolate

Transcutaneous

DEVICE

I-Box by Dynatronics

Electric field conducting drugs through the skin without compromising its integrity

Trial Locations (1)

10468

James J. Peters Veterans Affairs Medical Center, The Bronx

All Listed Sponsors
lead

James J. Peters Veterans Affairs Medical Center

FED